Literature DB >> 184868

Increased cerebral cyclic GMP concentration induced by muscarinic cholinergic agonists and prostaglandin F2alpha [proceedings].

S R Nahorski, C N Pratt, K J Rogers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 184868      PMCID： PMC1667216     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  6 in total

1.  Proceedings: Cyclic AMP in developing chick brain: changes with ischaemia and catecholamine administration.

Authors:  S R Nahorski; W Rees; K J Rogers
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  Cyclic adenosine 3',5'monophosphate role in the physiology and pharmacology of the central nervous system.

Authors:  J W Daly
Journal:  Biochem Pharmacol       Date:  1975-01-15       Impact factor: 5.858

3.  In vivo changes of cerebral cyclic adenosine 3',5'-monophosphate induced by biogenic amines: association with phosphorylase activation.

Authors:  C Edwards; S R Nahorski; K J Rogers
Journal:  J Neurochem       Date:  1974-04       Impact factor: 5.372

4.  A rapid and simple procedure for the determination of guanosine 3',5'-monophosphate by use of the protein-binding method.

Authors:  V Dinnendahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Freeze-blowing: a new technique for the study of brain in vivo.

Authors:  R L Veech; R L Harris; D Veloso; E H Veech
Journal:  J Neurochem       Date:  1973-01       Impact factor: 5.372

Review 6.  Cyclic GMP.

Authors:  N D Goldberg; R F O'Dea; M K Haddox
Journal:  Adv Cyclic Nucleotide Res       Date:  1973
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.